http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108607092-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243 |
| filingDate | 2018-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108607092-B |
| titleOfInvention | Application of angelica sinensis protein in preparation of medicine for assisting tumor treatment |
| abstract | The invention relates to the field of natural traditional Chinese medicine protein, in particular to application of angelica sinensis protein in preparing an auxiliary tumor treatment medicine; the N-terminal sequence of the angelica sinensis protein is GIQKTEVEAPSTVSA. The angelica protein is used for preparing an auxiliary tumor treatment medicament, and the damage of chemotherapy medicament cisplatin to the spleen of a mouse can be relieved by administering the angelica protein before chemotherapy; the angelica sinensis protein is given before radiotherapy, so that the peripheral blood leukocyte number, thymus index, spleen nodule number (CFU-S) and CAT activity of the spleen of a irradiated mouse are respectively and remarkably increased by 135%, 103%, 23%, 219% and 180%, GST and GSH-Px activity of the spleen of the irradiated mouse can be improved, spleen white marrow injury is improved, the overall protection effect is stronger than that of amifostine, and the weight reduction rate of the irradiated mouse can be remarkably reduced by 94%, so that the survival quality of the irradiated mouse is improved. |
| priorityDate | 2018-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 99.